NCT06892886 Using Immersive Virtual Reality for the Upper Limb Rehabilitation of Post-stroke Subjects
| NCT ID | NCT06892886 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital of Ferrara |
| Condition | Sub-acute Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2023-03-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2023-03-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Stroke produces brain damages that results in sensory, motor, and cognitive impairments which reduce the patient's quality of life and social participation. Upper limb recovery is a complex process whose goal is to allow the patients to gain, in part or completely, independence in daily living activities, for that it represents one of the most important rehabilitation focus. Virtual reality is a fairly recent approach able to simulate concrete movements and functional tasks in a higher dosage compared to other therapies. It seems that the use of VR could improve limb function, however, the amount of this gain is still unclear because of insufficient evidence. This study aims at quantitatively investigating the effectiveness of an HMD immersive virtual reality system on the upper limb functioning in subacute stroke survivors.
Eligibility Criteria
Inclusion Criteria: * diagnosis of first, ischemic or hemorrhagic, stroke verified by brain imaging within 4 week * upper limb motor impairment defined by an upper extremity score \<55 on the Fugl-Meyer Assessment Exclusion Criteria: * neurological conditions in addition to stroke that may affect motor function * other medical conditions likely to interfere with the ability to safely complete the study protocol * impaired cognitive functioning that influences the ability to give informed consent * severe neuropsychological disorders * visual impairment * severe upper-limb pain defined as \> 7 on the Visual Analogue Scale
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06892886 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Sub-acute Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06892886 currently recruiting?
Yes, NCT06892886 is actively recruiting participants. Contact the research team at sofia.straudi@unife.it for enrollment information.
Where is the NCT06892886 trial being conducted?
This trial is being conducted at Ferrara, Italy.
Who is sponsoring the NCT06892886 clinical trial?
NCT06892886 is sponsored by University Hospital of Ferrara. The trial plans to enroll 48 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.